CMRX Bathi saben saham sajrone rolas wulan pungkasan Chimerix Inc

Chimerix, Inc. (CMRX) develops anti-tumor agents through partnerships with public and private entities. The company complies with environmental chemical disposal regulations and strives for leadership in clinical trials. The annual net income per share trend visualizes the market consensus, while -0.99 determines the current status of the parameter, helping investors adjust their portfolios in a timely manner.

CMRX (Chimerix, Inc.) riwayat Bathi resik saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 26.04.2025

Chimerix Inc. - rincian analitis lan metrik utama (CMRX)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Chimerix, Inc.|CMRX - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Chimerix, Inc.|CMRX - Nilai Bisnis

- data nilai buku modal saham:

Nilai Buku saben Saham Chimerix|CMRX - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku chimerix.com|CMRX - Aset Perusahaan

- indikator beban utang lan likuiditas:

- indikator pendapatan resik lan kelipatan nilai:

CMRX - Bathi pungkasan|Bathi mangsa ngarep Chimerix, Inc.|CMRX - Rasio rega pasar marang bathi resik|Pangali Forward P/E Chimerix|CMRX - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Chimerix, Inc.|CMRX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Chimerix|CMRX - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan chimerix.com|CMRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Chimerix, Inc.

Analisis dhasar perusahaan:Chimerix, Inc. (CMRX)

Government contracts with BARDA and oncology partnerships provide Chimerix, Inc. (CMRX) with strategic resilience. This indicator reflects the aggregate annual net income distributed per common share based on 10-K and 10-Q data. It is critical for investors to assess real capital efficiency while excluding reporting lags. Analysis requires a balance between market sentiment and fundamental value. Net income per share dynamics allow for the timely identification of asset overvaluation.

Analisis perusahaan pesaing